The DEA opened up applications for manufacturing Schedule 1 Cannabis under FDA GMP Regulations in August 2016. One year later, no applications have been granted. Without GMP Cannabis, there will be no legitimate medical research. Take a moment to copy and paste our letter to your congress person.